The Pfizer Inc team will be honored Sept. 7 at the American Chemical Society's 226th national meeting in New York along with chemists from Abbott Laboratories, Merck Research Industries and Wyeth Pharmaceuticals. The Pfizer Inc researchers are Johannes H. Hartenstein, Ph.D., Gerhard Satzinger, Ph.D., and James R. Zeller, Ph.D.
"The broad range of invaluable products that our Heroes of Chemistry have developed and commercialized has dramatically advanced the health, well-being and lifestyles of children around the world," said ACS President Elsa Reichmanis, Ph.D. "The chemical advances made by the honorees serve as testimonials to the valuable role chemists and chemical engineers play in improving lives. It is with pride that the ACS recognizes them as Heroes of Chemistry."
Epilepsy is common in children, with 75 percent of the cases developing before the age of 20. Neurontin® has no reactions with other drugs and this is significant since many children with epilepsy also have other conditions which require medication. The drug controls seizures and, because many children with epilepsy have normal cognition, they can live normal lives when the episodes subside.
The Heroes of Chemistry program will be held in conjunction with a celebration for the 80th anniversary of Chemical & Engineering News, the society's newsmagazine. Benjamin S. Carson, Sr., M.D., director of the Division of Pediatric Neurosurgery at Johns Hopkins University, will be the keynote speaker at the joint event. Carson has gained worldwide recognition as the principal surgeon in the separation of the conjoined Binder twins in Germany and, most recently, for his role in the separation of the Bij
'"/>
Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
22-Aug-2003